The constant activation of mTOR leads to uncontrolled growth and metabolic reprogramming characterized by enhanced glycolysis and amino acid uptake, which not only fuels tumor cell anabolism but also shapes the immune microenvironment (Kim et al., 2017). The gene discussed is MTOR; the disease is neoplasm.